SEC Filing Summary: Conduit Pharmaceuticals Inc. (CDT)
Business Context and Reporting Period
This Form 8-K Current Report, dated January 22, 2025, pertains to Conduit Pharmaceuticals Inc., a Delaware corporation. The filing announces a material corporate action approved by stockholders at the annual meeting on December 18, 2024.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a capital structure modification.
Material Changes
- Reverse Stock Split: The Company filed a certificate of amendment to effectuate a 1-for-100 reverse stock split of its outstanding common stock.
- Effective Date: The split becomes effective on January 24, 2025, at 5:00 p.m. Eastern Time.
- Trading Resumption: Common stock is expected to begin trading on a split-adjusted basis on The Nasdaq Global Market on January 27, 2025, under the existing ticker symbol "CDT."
- Share Consolidation: Every 100 shares of issued and outstanding Common Stock will be combined into one share.
- Fractional Shares: No fractional shares will be issued. Stockholders entitled to fractional shares will receive a cash payment based on the closing price on January 24, 2025.
- CUSIP Update: The post-split Common Stock CUSIP number will be 20678X 205.
Guidance, Outlook, and Risks
The filing includes forward-looking statements regarding the Reverse Stock Split and its potential impacts. The Company disclaims any obligation to update these statements. No specific financial guidance or operational outlook is provided in this document. The primary risk noted is that actual results may differ materially from forward-looking statements due to various uncertainties.
Investor Verification Checklist
- Confirm the effective time of the 1-for-100 reverse stock split (January 24, 2025, 5:00 p.m. ET).
- Verify the new CUSIP number (20678X 205) for post-split trading.
- Check the closing price on January 24, 2025, to determine cash-in-lieu payments for fractional shares.
- Monitor trading resumption on January 27, 2025, under the ticker "CDT."
- Review the Certificate of Amendment (Exhibit 3.1) for full legal terms.